Netscientific PLC (NSCI) Stock Rating Reaffirmed by Stifel Nicolaus
Netscientific PLC (LON:NSCI)‘s stock had its “buy” rating restated by Stifel Nicolaus in a research note issued to investors on Tuesday. They currently have a GBX 95 ($1.25) target price on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 48.44% from the company’s previous close.
Shares of Netscientific PLC (LON:NSCI) opened at GBX 64 ($0.84) on Tuesday. Netscientific PLC has a 12-month low of GBX 36 ($0.47) and a 12-month high of GBX 73.80 ($0.97).
Netscientific PLC (LON:NSCI) last posted its quarterly earnings results on Thursday, September 28th. The company reported GBX (8.80) (($0.12)) earnings per share (EPS) for the quarter. Netscientific PLC had a negative net margin of 3,144.51% and a negative return on equity of 51.79%. The business had revenue of GBX 16 million during the quarter.
About Netscientific PLC
NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics.
Receive News & Ratings for Netscientific PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Netscientific PLC and related companies with MarketBeat.com's FREE daily email newsletter.